MATERIALS AND METHODS: Relevant prospective studies were identified by a search of Medline and Embase databases to 03 October 2011. Twelve studies on localized PCa (1 033 009 men, 19 130 cases) and 13 on advanced PCa (1 080 790 men, 7067 cases) were identified. We carried out a dose-response meta-analysis using random-effects model.
RESULTS: For localized PCa, we observed an inverse linear relationship with BMI [Ptrend < 0.001, relative risk (RR): 0.94 (95% confidence interval, 95% CI, 0.91-0.97) for every 5 kg/m2 increase]; there was no evidence of heterogeneity (Pheterogeneity = 0.27). For advanced PCa, we observed a linear direct relationship with BMI (Ptrend = 0.001, RR: 1.09 (95% CI 1.02-1.16) for every 5 kg/m2 increase); there was weak evidence of heterogeneity (Pheterogeneity = 0.08). Omitting one study that contributed substantially to the heterogeneity yielded a pooled RR of 1.07 (95% CI 1.01-1.13) for every 5 kg/m2 increase (Pheterogeneity = 0.26).
CONCLUSIONS: The quantitative summary of the accumulated evidence indicates that obesity may have a dual effect on PCa-a decreased risk for localized PCa and an increased risk for advanced PCa.
Written by:
Discacciati A, Orsini N, Wolk A. Are you the author?
Nutritional Epidemiology Unit, Division of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Reference: Ann Oncol. 2012 Jan 6. Epub ahead of print.
doi: 10.1093/annonc/mdr603
PubMed Abstract
PMID: 22228452
UroToday.com Prostate Cancer Section
